Literature DB >> 10624592

Negative predictors of survival in HIV-infected patients with culture-confirmed pulmonary tuberculosis.

F Palmieri1, A M Pellicelli, E Girardi, A P De Felici, P De Mori, N Petrosillo, G Ippolito.   

Abstract

We performed a retrospective study based on chart review of 118 HIV-infected patients with culture-confirmed pulmonary TB, in which M. tuberculosis isolates were tested for drug susceptibility. Patients were enrolled in the period January 1987 to December 1996 and followed until September 1997. The median survival for the entire cohort was 15.2 months with a 1-year survival rate of 57%. Prior AIDS-defining illness, low CD4 count (< 200/mm3), not having received antituberculous therapy with at least two drugs to which M. tuberculosis was susceptible in vitro, starting within four weeks of diagnosis, treatment duration of less than three weeks and multidrug resistant tuberculosis were each independently associated with decreased survival in multivariate analysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10624592     DOI: 10.1007/s150100050038

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  5 in total

1.  Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.

Authors:  Rinat Sergeev; Caroline Colijn; Megan Murray; Ted Cohen
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

2.  Mycobacterium bovis BCG-induced granuloma formation depends on gamma interferon and CD40 ligand but does not require CD28.

Authors:  L H Hogan; W Markofski; A Bock; B Barger; J D Morrissey; M Sandor
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  HIV-specific health care utilization and mortality among tuberculosis/HIV coinfected persons.

Authors:  L Beth Gadkowski; Carol D Hamilton; Myra Allen; Ellen R Fortenberry; Julie Luffman; Elizabeth Zeringue; Jason E Stout
Journal:  AIDS Patient Care STDS       Date:  2009-10       Impact factor: 5.078

4.  Effectiveness of early antiretroviral therapy initiation to improve survival among HIV-infected adults with tuberculosis: a retrospective cohort study.

Authors:  Molly F Franke; James M Robins; Jules Mugabo; Felix Kaigamba; Lauren E Cain; Julia G Fleming; Megan B Murray
Journal:  PLoS Med       Date:  2011-05-03       Impact factor: 11.069

5.  Predictors of death during tuberculosis treatment in TB/HIV co-infected patients in Malaysia.

Authors:  Ismawati Ismail; Awang Bulgiba
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.